Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (471-480 of 681) with videos related to

Pageof 69
Sort By:
Eating Behaviors|January 3, 2008
The Night Eating Questionnaire (NEQ): psychometric properties of a measure of severity of the Night Eating SyndromeKelly C Allison, Jennifer D Lundgren, John P O'Reardon, et al.
AIDS (London, England)|January 10, 2015
Thrombocytopenia is associated with an increased risk of cancer during treated HIV diseaseÁlvaro H Borges, Jens D Lundgren, Annalisa Ridolfo, et al.
AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
AIDS (London, England)|April 7, 2007
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Lidia Ruiz, et al.
The Journal of Infectious Diseases|July 17, 2009
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settingsAlessandro Cozzi-Lepri, Andrew N Phillips, Javier Martinez-Picado, et al.
AIDS (London, England)|December 24, 2013
Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive personsLene Ryom, Amanda Mocroft, Ole Kirk, et al.
Journal of Cancer Research and Clinical Oncology|October 7, 2019
"Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation"Neval E Wareham, Qiuju Li, Henrik Sengeløv, et al.
The Journal of Infectious Diseases|May 2, 2016
Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV InfectionÁlvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.
Health Laboratory Science|October 1, 1973
Tentative method of analysis for atmospheric visibility (integrating nephelometer method)R A Herrick, S Kinsman, J Lodge, et al.
HIV Medicine|February 9, 2008
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIVJ D Lundgren, M Battegay, G Behrens, et al.
Pageof 69

Showing results (471-480 of 681) with videos related to

Sort By:
Pageof 69
Eating Behaviors|January 3, 2008
The Night Eating Questionnaire (NEQ): psychometric properties of a measure of severity of the Night Eating SyndromeKelly C Allison, Jennifer D Lundgren, John P O'Reardon, et al.
AIDS (London, England)|January 10, 2015
Thrombocytopenia is associated with an increased risk of cancer during treated HIV diseaseÁlvaro H Borges, Jens D Lundgren, Annalisa Ridolfo, et al.
AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
AIDS (London, England)|April 7, 2007
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Lidia Ruiz, et al.
The Journal of Infectious Diseases|July 17, 2009
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settingsAlessandro Cozzi-Lepri, Andrew N Phillips, Javier Martinez-Picado, et al.
AIDS (London, England)|December 24, 2013
Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive personsLene Ryom, Amanda Mocroft, Ole Kirk, et al.
Journal of Cancer Research and Clinical Oncology|October 7, 2019
"Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation"Neval E Wareham, Qiuju Li, Henrik Sengeløv, et al.
The Journal of Infectious Diseases|May 2, 2016
Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV InfectionÁlvaro H Borges, Jemma L O'Connor, Andrew N Phillips, et al.
Health Laboratory Science|October 1, 1973
Tentative method of analysis for atmospheric visibility (integrating nephelometer method)R A Herrick, S Kinsman, J Lodge, et al.
HIV Medicine|February 9, 2008
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIVJ D Lundgren, M Battegay, G Behrens, et al.
Pageof 69